Medium for the protein-free and serum-free cultivation of cells

US9982286B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9982286-B2
Application numberUS-201615235453-A
CountryUS
Kind codeB2
Filing dateAug 12, 2016
Priority dateSep 28, 1999
Publication dateMay 29, 2018
Grant dateMay 29, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medium is described for the protein-free and serum-free cultivation of cells, especially mammalian cells, whereby the medium contains a proportion of soy hydrolysate.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for increasing productivity of a recombinant protein in a cell culture, the method comprising: culturing mammalian cells that express the recombinant protein in an animal protein-free and serum-free cell culture medium; and adding more than 10 wt. % ultrafiltered soy hydrolysate based on the total dry weight of the medium to the animal protein-free and serum-free cell culture medium, wherein at least 40% of the soy hydrolysate has a molecular weight of ≤500 daltons. 2. The method of claim 1 , wherein at least 50% of the soy hydrolysate has a molecular weight of ≤500 daltons. 3. The method of claim 1 , wherein at least 55% of the soy hydrolysate has a molecular weight of ≤500 daltons. 4. The method of claim 1 , wherein the soy hydrolysate has an endotoxin content of <500 U/g. 5. The method of claim 1 , wherein the mammalian cells are CHO cells or BHK cells. 6. The method of claim 1 , wherein the recombinant protein is selected from the group consisting of: Factor II, Factor V, Factor VII, Factor VIII, Factor IX, Factor X, Factor XI, Protein S, Protein C, activated forms of these factors, and vWF. 7. The method of claim 6 , wherein the recombinant protein is Factor VIII. 8. The method of claim 1 , wherein the medium comprises an amino acid. 9. The method of claim 8 , wherein the amino acid is selected from the group consisting of L-asparagine, L-cysteine, L-cystine, L-proline, L-tryptophan, L-glutamine and mixtures thereof. 10. The method of claim 1 , wherein the medium further comprises: 1 to 100 g/L synthetic minimal medium; 0.05-1 g/L glutamine; 0.0005-0.05 g/L ascorbic acid; 0.1-10 g/L NaHCO 3 ; 0.0005-0.05 g/L ethanolamine; and 1-15 μg/L sodium selenite. 11. The method of claim 1 , wherein the cells are cultured in a bioreactor.

Assignees

Inventors

Classifications

  • from plants · CPC title

  • Serum-free medium, which may still contain naturally-sourced components · CPC title

  • Protein-free medium · CPC title

  • Amines, e.g. putrescine · CPC title

  • Inorganic components · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9982286B2 cover?
A medium is described for the protein-free and serum-free cultivation of cells, especially mammalian cells, whereby the medium contains a proportion of soy hydrolysate.
Who is the assignee on this patent?
Baxalta Inc, Baxalta GmbH
What technology area does this patent fall under?
Primary CPC classification C12P21/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).